WASHINGTON (dpa-AFX) - QIAGEN N.V. (QGEN) announced Monday that Jonathan Pratt has been appointed Chief Executive Officer, effective September 1, 2026. He brings to QIAGEN more than 25 years of international leadership experience across life sciences, laboratory technologies and healthcare.
The company said Thierry Bernard will step down as CEO and Managing Director and will support an orderly transition through the end of the year.
Pratt most recently served as President and CEO of Filtration Group, leading the business through the completion of its sale to Parker-Hannifin Corp. in August 2026.
Pratt previously served as Senior Vice President of the Waters Division at Waters Corp. and as President of Beckman Coulter Life Sciences, a Danaher operating company, and held senior leadership positions at Pall Corporation.
Throughout his career, he has led global businesses spanning analytical instruments, laboratory technologies, software, consumables, services and bioprocessing applications.
Pratt's experience includes commercial execution, portfolio management, operations and organizational development in markets closely aligned with QIAGEN's portfolio and customer workflows.
He will also be proposed for shareholder approval as a Managing Director at an Extraordinary General Meeting planned for the fourth quarter of 2026.
QIAGEN also reaffirmed its outlook for the third quarter and full-year 2026.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
